- The United Nations Commission on Narcotic Drugs discusses the implementation of international drug control treaties during a full session Tuesday in Vienna.
- A United Nations drug policy agency this week is expected to postpone a vote on the World Health Organization’s cannabis scheduling recommendations, prompting a U.S. representative in Vienna to voice regret over the delay.
- The expected delay by the United Nations Commission on Narcotic Drugs (CND) involves several changes to how cannabis is scheduled in international drug control treaties, a decision that would have significant implications for the regulated industry.
- We do regret that the CND was unable to take action on the WHO cannabis recommendations this week, given that Member States have been working hard since February 2019 to engage in an in-depth consultative process on the legal, administrative, social and economic impacts of the recommendations, James Walsh, the U.S. representative, said in a statement.
- The U.N. body decides to continue during its current 63rd session the consideration of the recommendations of the World Health Organization on cannabis and cannabis-related substances, bearing in mind their complexity, in order to clarify the implications and consequences of, as well as the reasoning for, these recommendations, Khan wrote in a statement.
Read full article: mjbizdaily.com